Franklin Resources
SGYP

Franklin Resources’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Franklin Resources’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,036,467
Closed -$5.62M – 1571
2016
Q1 		$5.62M Hold
2,036,467
– – ﹤0.01% 1081
2015
Q4 		$11.5M Hold
2,036,467
– – 0.01% 978
2015
Q3 		$10.8M Buy
2,036,467
+67,767
+3% +$524K 0.01% 997
2015
Q2 		$16.3M Buy
+1,968,700
New +$9.5M 0.01% 933

Other funds holding SGYP

Paulson & Co
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Great Point Partners
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources's SGYP Position: Q2 2016 in Review

Franklin Resources sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2016, closing a stake of 2,036,467 shares — an estimated $5.62M sold.

Franklin Resources first reported a position in SGYP in Q2 2015 and held it in 4 quarters. The position peaked at $16.3M in Q2 2015. 134 funds tracked by Wall St. Rank hold SGYP as of Q2 2016.

  • Franklin Resources reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2016 after selling out during the quarter.
  • Franklin Resources sold 2,036,467 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2016, an estimated $5.62M.
  • Franklin Resources first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 4 quarters.
  • Franklin Resources's Synergy Pharmaceuticals, Inc Common Stock position peaked at $16.3M in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2016.

Based on Franklin Resources's 13F filing for Q2 2016, filed 11 Aug 2016.